Medical Properties Trust stock edges lower after hospital sale

Published on 09/17/2026 at 15:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medical Properties Trust stock traded at USD 3.39 on September 16, 2026, after a 52-week low of USD 3.50. The company booked USD 259.28 million of second-quarter 2026 revenue and USD 371 million in cash proceeds.

MPW, US58463J3041, Illustration mit AI erstellt.

Medical Properties Trust stock (ISIN US58463J3041) traded at USD 3.39 on the NYSE on September 16, 2026, after an intraday 52-week low of USD 3.50 and a day change of -4.24 percent. The latest company update came through Investing.com, which reported on September 16, 2026 that the trust sold two Idaho hospitals for USD 413 million.

Cash proceeds matter most

The same report said the transaction generated USD 371 million in cash proceeds for the company, while the remaining USD 42 million went to minority real estate owners. It also said the deal formed part of about USD 680 million in total cash proceeds received during the third quarter.

For investors, that makes balance-sheet repair more visible than the headline sale price. The gap between the USD 413 million transaction value and the USD 371 million cash inflow is the key detail.

Quarterly figures stay in view

Separately, Investing.com said on September 16, 2026 that Medical Properties Trust reported second-quarter 2026 revenue of USD 259.28 million, above Wall Street expectations of USD 248.01 million. The same item put quarterly earnings at a loss of USD 0.01 per share and normalized funds from operations at USD 0.15 per share.

MarketBeat said on September 17, 2026 that the stock had a market capitalization of USD 2.03 billion, a 52-week range of USD 3.39 to USD 6.47 and a dividend yield of 10.59 percent. It also listed a consensus price target of USD 4.15, or about 22.1 percent above the current price.

Price sits near the floor

Medical Properties Trust stock ended at USD 3.39 on September 16, 2026, with volume of 14.99 million shares. The price stayed at the bottom of the reported 52-week band of USD 3.39 to USD 6.47.